Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Research Tools and Instruments

McMaster University

$150,000.00

Self-driving Microphysiological Systems Lab

FY 2023-24

Summary
Microphysiological systems, also known as Organ-on-a-Chip and Organoids technology have significantly advanced, refining drug discovery and reducing the need for animal testing. Yet, there's a pressing demand to enhance the experimental throughput of these advanced tissue models to maximize data collection. While our team has made considerable strides in creating high-throughput Organ-on-a-Chip platforms, the continuous data acquisition and successive live imaging remains a time-consuming task. This challenge can be addressed by the requested Agilent BioSpa+BioTek system (Fisher Scientific). This system is a newly introduced automated solution integrating an automated incubator (BioSpa), a Cytation cell imaging multimode reader (BioTek), and a robotic arm. This key acquisition will propel us closer to the establishment of a fully automated Self-driving Microphysiological System Lab, aiming to fully streamline tissue production and analysis. While lab automation is undeniably the direction of the future, it often comes with a hefty price tag. This sought-after equipment will complement our existing CFI-funded assets, finalizing a self-driving lab suite that includes a robotic liquid handling system and a 3D bioprinter, thus amplifying the utility of all our resources. Thanks to the support of multiple grants, our team has pioneered a range of tissue models and projects set to benefit immensely from this equipment: 1.Sex-specific kidney proximal tubule models for drug toxicity screening 2.Optimization of mRNA nanoparticle delivery in lung airway and alveolar models. 3.Vascularized placenta model for studying drug transport. 4.Organoid morphology classification using machine learning Beyond these specific research initiatives, the proposed equipment will also be an asset to other McMaster labs focused on cancer research, DNA nanomaterials discovery, and tissue engineering, among others. Forecasts from Business Wire indicate that research domains necessitating advanced bioimaging and automation will account for market sizes of $11 billion and $9 billion respectively by 2026. This suggests immense current and upcoming economic opportunities. As a result, training on this forefront instrument, combined with our established bioengineering program, will make our trainees prime candidates for employers across various biotech sectors.
Program
Research Tools and Instruments
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RTI-2024-00588
Name nom
Zhang, Boyang
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2024
Award amount
150000
Program id
RTI
Program name en
Research Tools and Instruments
Program name fr
Outils et instruments de recherche
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1611
Committee name en
Materials and Chemical Engineering (RTI)
Committee name fr
Génie chimique et des matériaux (OIR)
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Biomedical materials
Research subject en
Génie biomédical
Research subject fr
Matériaux biomédicaux
Application title
Self-driving Microphysiological Systems Lab
Keyword
3D tissue culture; Automation; Drug discovery; High throughput screening; Imaging; Microphysiological systems; Organoids; Organ--on--a--Chip; Robotic system; Tissue Engineering
Application summary
Microphysiological systems, also known as Organ-on-a-Chip and Organoids technology have significantly advanced, refining drug discovery and reducing the need for animal testing. Yet, there's a pressing demand to enhance the experimental throughput of these advanced tissue models to maximize data collection. While our team has made considerable strides in creating high-throughput Organ-on-a-Chip platforms, the continuous data acquisition and successive live imaging remains a time-consuming task. This challenge can be addressed by the requested Agilent BioSpa+BioTek system (Fisher Scientific). This system is a newly introduced automated solution integrating an automated incubator (BioSpa), a Cytation cell imaging multimode reader (BioTek), and a robotic arm. This key acquisition will propel us closer to the establishment of a fully automated Self-driving Microphysiological System Lab, aiming to fully streamline tissue production and analysis. While lab automation is undeniably the direction of the future, it often comes with a hefty price tag. This sought-after equipment will complement our existing CFI-funded assets, finalizing a self-driving lab suite that includes a robotic liquid handling system and a 3D bioprinter, thus amplifying the utility of all our resources. Thanks to the support of multiple grants, our team has pioneered a range of tissue models and projects set to benefit immensely from this equipment: 1.Sex-specific kidney proximal tubule models for drug toxicity screening 2.Optimization of mRNA nanoparticle delivery in lung airway and alveolar models. 3.Vascularized placenta model for studying drug transport. 4.Organoid morphology classification using machine learning Beyond these specific research initiatives, the proposed equipment will also be an asset to other McMaster labs focused on cancer research, DNA nanomaterials discovery, and tissue engineering, among others. Forecasts from Business Wire indicate that research domains necessitating advanced bioimaging and automation will account for market sizes of $11 billion and $9 billion respectively by 2026. This suggests immense current and upcoming economic opportunities. As a result, training on this forefront instrument, combined with our established bioengineering program, will make our trainees prime candidates for employers across various biotech sectors.
McMaster University - $150,000 Grant (2023-24) | Canada Spends